The new oral drug has been developed by a pharmaceutical company and its phase I of trial was earlier conducted in the USA. A similar study on phase II was also in progress at Kala-azar Medical Research Centre (KAMRC), Muzaffarpur, by a team led by Prof Shyam Sundar., The new oral drug has been developed by a pharmaceutical company and its phase I of trial was earlier conducted in the USA. A similar study on phase II was also in progress at Kala-azar Medical Research Centre (KAMRC), Muzaffarpur, by a team led by Prof Shyam Sundar., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way